# Clinical trials recruiting in Maryland: 2,715 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 2,715 trials recruiting or not yet recruiting with a site in Maryland, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Maryland: 2,715 rows for $107.15, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 44 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/maryland

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 2,715
- Recruiting or not yet: 2,715
- Read on: November 19, 2026

## Trials

The 25 newest of 2,715, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946341 | A Study in Healthy Participants With Elevated LDL-C to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS060380 | Cascade Pharmaceuticals, Inc | Phase 1 | Not yet recruiting | MASH (Metabolic Dysfunction-Associated Steatohepatitis) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946341) |
| November 18, 2026 | NCT07945041 | Optimizing Acute Care Rehabilitation for Critically Ill Adults | University of Colorado, Denver | Not applicable | Not yet recruiting | ICU Acquired Muscle Weakness, Critical Illness, Functional Impairment, Rehabilitation After Critical Illness | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945041) |
| November 17, 2026 | NCT07940751 | Screening fOR Throat Cancer | Johns Hopkins University | Observational | Not yet recruiting | Oropharyngeal Cancer, Human Papillomavirus | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940751) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07930585 | Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M in Healthy Malaria-Naive Adults Using a Plasmodium Vivax Controlled Human Malaria... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1/2 | Not yet recruiting | Healthy Volunteers, Malaria, Plasmodium Vivax | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930585) |
| November 10, 2026 | NCT07927413 | Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients | Corza Medical GmbH | Observational | Recruiting | Cerebrospinal Fluid (CSF) Leak, Psuedomeningocele | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927413) |
| November 10, 2026 | NCT07927166 | Local Antibiotic Delivery From an Intramedullary Nail After Surgical Treatment of Tibial Fractures at High Risk of Infection | Reselute, Inc. | Not applicable | Not yet recruiting | Tibial Fractures, Fractures, Open | 317 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927166) |
| November 9, 2026 | NCT07923903 | Research Participant Registry "Hopkins Opportunities for Participant Engagement" | Johns Hopkins University | Observational | Not yet recruiting | Research Participation, Recruitment, Engagement, Research Awareness | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923903) |
| November 6, 2026 | NCT07920952 | Effects of Ad Libitum Ultra-Processed Diet on Brain Dopamine in Humans | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Not applicable | Not yet recruiting | Healthy Volunteers | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920952) |
| November 5, 2026 | NCT07920081 | Psilocybin for Amblyopia - Targeting Critical Periods in Humans | Johns Hopkins University | Phase 1/2 | Recruiting | Amblyopia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920081) |
| November 5, 2026 | NCT07919782 | Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair | Restore Biologics Holdings, Inc. dba Xtressé | Not applicable | Not yet recruiting | Androgenetic Alopecia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919782) |
| November 4, 2026 | NCT07916259 | The Study of Brave-LC LDN Treatment Trial | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Post-acute COVID-19 Syndrome | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916259) |
| November 4, 2026 | NCT07915791 | A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe... | GlaxoSmithKline | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 279 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915791) |
| November 4, 2026 | NCT07914816 | Phase 2 Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB) Injection for the Treatment of Infraorbital Hollowing | Lynch Regenerative Medicine | Phase 2 | Not yet recruiting | Infra-orbital Hollows, Skin Quality Improvement | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914816) |
| November 3, 2026 | NCT07912242 | Cerebellar Brain Stimulation Plus Language Therapy for People at Risk of Poor Aphasia Recovery After Stroke | Johns Hopkins University | Not applicable | Not yet recruiting | Aphasia, Stroke, Anomia | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912242) |
| November 2, 2026 | NCT07911319 | TiUltra Implant Study | University of Maryland, Baltimore | Phase 4 | Not yet recruiting | Missing Tooth/Teeth | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911319) |
| November 2, 2026 | NCT07910617 | Environmental Harm Menu Labels and Overall Dietary Quality | Johns Hopkins Bloomberg School of Public Health | Not applicable | Recruiting | Food Choices | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910617) |
| November 2, 2026 | NCT07910604 | Environmental Harm Menu Labels and the Healthfulness of Real-World Fast-Food Orders | Johns Hopkins Bloomberg School of Public Health | Not applicable | Recruiting | Food Choices | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910604) |
| October 29, 2026 | NCT07902921 | STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic... | National Cancer Institute (NCI) | Phase 1/2 | Not yet recruiting | NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas... | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902921) |
| October 29, 2026 | NCT07902908 | Use of a Mandibular Advancement Appliance in Children With Obstructive Sleep Apnea | National Institute of Dental and Craniofacial Research (NIDCR) | Not applicable | Not yet recruiting | Obstructive Sleep Apnea (OSA), Pediatric Obstructive Sleep Apnea (OSA), Adeno-Tonsillar Hypertrophy, Maxillary... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902908) |
| October 28, 2026 | NCT07900828 | Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment | Johns Hopkins University | Not applicable | Not yet recruiting | Opioid Use Disorder | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900828) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07898085 | Nutrition Intervention for Older Adults and Research Training | University of Maryland, Baltimore | Not applicable | Not yet recruiting | Impaired Mobility | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898085) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| National Institutes of Health Clinical Center | Bethesda | 618 |
| Johns Hopkins University | Baltimore | 186 |
| Johns Hopkins Hospital | Baltimore | 129 |
| Walter Reed National Military Medical Center | Bethesda | 76 |
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | 74 |
| University of Maryland | Baltimore | 66 |
| Sinai Hospital of Baltimore | Baltimore | 53 |
| University of Maryland/Greenebaum Cancer Center | Baltimore | 52 |
| University of Maryland Medical Center | Baltimore | 50 |
| Johns Hopkins University School of Medicine | Baltimore | 43 |
| Johns Hopkins School of Medicine | Baltimore | 30 |
| Greater Baltimore Medical Center | Baltimore | 28 |
| Kennedy Krieger Institute | Baltimore | 28 |
| University of Maryland School of Medicine | Baltimore | 25 |
| University of Maryland, Baltimore | Baltimore | 24 |
| The Johns Hopkins Hospital | Baltimore | 23 |
| Christiana Care - Union Hospital | Elkton | 23 |
| UM Baltimore Washington Medical Center/Tate Cancer Center | Glen Burnie | 22 |
| Johns Hopkins Bayview Medical Center | Baltimore | 22 |
| UM Upper Chesapeake Medical Center | Bel Air | 18 |
| Johns Hopkins Medicine | Baltimore | 18 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | 17 |
| Maryland Proton Treatment Center | Baltimore | 16 |
| William E Kahlert Regional Cancer Center/Sinai Hospital | Westminster | 16 |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | 16 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 23 |
| Phase 1 | 243 |
| Phase 1/2 | 156 |
| Phase 2 | 454 |
| Phase 2/3 | 52 |
| Phase 3 | 526 |
| Phase 4 | 73 |
| Not applicable | 467 |
| Observational | 721 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 90 |
| Neoplasms | 76 |
| Prostatic Neoplasms | 73 |
| Breast Neoplasms | 71 |
| Lung Neoplasms | 64 |
| Obesity | 62 |
| Neoplasm Metastasis | 54 |
| Colorectal Neoplasms | 51 |
| Pancreatic Neoplasms | 48 |
| Urinary Bladder Neoplasms | 38 |
| Overweight | 38 |
| Ovarian Neoplasms | 38 |
| Depression | 34 |
| Leukemia, Myeloid, Acute | 33 |
| Stroke | 32 |
| Recurrence | 32 |
| Diabetes Mellitus, Type 2 | 31 |
| Hematologic Neoplasms | 30 |
| Heart Failure | 29 |
| Cardiovascular Diseases | 28 |
| Endometrial Neoplasms | 27 |
| Multiple Myeloma | 27 |
| Melanoma | 27 |
| Colonic Neoplasms | 26 |
| Alcoholism | 24 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Johns Hopkins University | 253 |
| National Cancer Institute (NCI) | 226 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 119 |
| University of Maryland, Baltimore | 107 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 77 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 66 |
| National Heart, Lung, and Blood Institute (NHLBI) | 58 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 54 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 45 |
| National Institute of Mental Health (NIMH) | 45 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 35 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 32 |
| National Human Genome Research Institute (NHGRI) | 28 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 25 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 24 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 23 |
| Children's Oncology Group | 23 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 22 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 21 |
| VA Office of Research and Development | 21 |
| National Institutes of Health Clinical Center (CC) | 21 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 20 |
| SWOG Cancer Research Network | 18 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 18 |
| National Eye Institute (NEI) | 17 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Maryland

- [B2B water treatment companies in Maryland, United States](https://specstream.ai/data/businesses/b2b-water-treatment-companies/maryland-united-states)
- [Wine bars in Maryland, United States](https://specstream.ai/data/businesses/wine-bars/maryland-united-states)
- [Tex-Mex restaurants in Maryland, United States](https://specstream.ai/data/businesses/tex-mex-restaurants/maryland-united-states)
- [Roofing contractors in Maryland, United States](https://specstream.ai/data/businesses/roofing-contractors/maryland-united-states)
- [Prenatal and perinatal care clinics in Maryland, United States](https://specstream.ai/data/businesses/prenatal-and-perinatal-care-clinics/maryland-united-states)
- [Obstetrics and gynecology practices in Maryland, United States](https://specstream.ai/data/businesses/obstetrics-and-gynecology-practices/maryland-united-states)
